Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

SELL
$0.22 - $1.04 $17,451 - $82,498
-79,325 Reduced 4.59%
1,648,979 $435,000
Q3 2022

Nov 14, 2022

BUY
$0.25 - $2.4 $8,725 - $83,764
34,902 Added 2.06%
1,728,304 $1.52 Million
Q2 2022

Aug 15, 2022

SELL
$1.22 - $3.05 $152,364 - $380,911
-124,889 Reduced 6.87%
1,693,402 $2.13 Million
Q1 2022

May 16, 2022

SELL
$2.64 - $4.67 $2.94 Million - $5.2 Million
-1,114,267 Reduced 38.0%
1,818,291 $5.58 Million
Q4 2021

Feb 14, 2022

BUY
$4.4 - $8.8 $352,585 - $705,170
80,133 Added 2.81%
2,932,558 $13.1 Million
Q3 2021

Nov 15, 2021

BUY
$7.44 - $13.99 $21.2 Million - $39.9 Million
2,852,425 New
2,852,425 $21.7 Million

Others Institutions Holding SMFR

About Sema4 Holdings Corp.


  • Ticker SMFR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 380,641,984
  • Market Cap $129M
  • Description
  • Sema4 Holdings Corp., doing business as Sema4, operates as a health information company that enhances diagnosis, treatment, and prevention of disease through data. The company provides Centrellis, an AI-driven health intelligence platform that delivers comprehensive insights to biopharma to accelerate the drug discovery, development, and commerc...
More about SMFR
Track This Portfolio

Track Price T Rowe Associates Inc Portfolio

Follow Price T Rowe Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.